Guardant Health, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2026-06-05 pm EDT			5-day change	1st Jan Change
125.61 ^USD	-5.60%		-3.15%	+22.98%

Jun. 02	Evercore ISI Upgrades Guardant Health to Outperform From In Line, Adjusts PT to $160 From $95	MT
May. 29	Guardant Health Insider Sold Shares Worth $1,250,836, According to a Recent SEC Filing	MT

Published on 05/07/2026 at 09:31 pm EDT - Modified on 05/08/2026 at 05:05 am EDT

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good afternoon. Thank you for attending the Guardant Health Q1 2026 Earnings Call. My name is Matt, and I'll be the moderator for today's call.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Jun. 02	Evercore ISI Upgrades Guardant Health to Outperform From In Line, Adjusts PT to $160 From $95	MT
May. 29	Guardant Health Insider Sold Shares Worth $1,250,836, According to a Recent SEC Filing	MT
May. 27	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Amid S&P 500, Nasdaq Rally, Middle East Peace Optimism	MT
May. 27	Guardant Health Says Shield Blood Test Included in American Cancer Society Guidelines	MT
May. 27	Guardant Health Shield Blood Test Included in Updated American Cancer Society Colorectal Cancer Screening Guidelines	CI
May. 27	Blood test added to US colorectal cancer screening options	RE
May. 26	Guardant Health Insider Sold Shares Worth $2,896,360, According to a Recent SEC Filing	MT
May. 22	Guardant Health Insider Sold Shares Worth $735,049, According to a Recent SEC Filing	MT
May. 22	Guardant Health Insider Sold Shares Worth $23,076,690, According to a Recent SEC Filing	MT
May. 22	Guardant Health Insider Sold Shares Worth $2,130,229, According to a Recent SEC Filing	MT
May. 20	Guardant Health Says US FDA Approved Liquid Biopsy Test	MT
May. 20	Fda approves new Guardant360 liquid cdx, the largest FDA-approved liquid biopsy panel with a 100x expanded footprint	RE
May. 20	Guardant Health Announces Fda Approval Of Guardant360 Liquid Cdx, The Largest Fda-Approved Liquid Biopsy Panel	CI
May. 13	Guardant Health Insider Sold Shares Worth $5,016,000, According to a Recent SEC Filing	MT
May. 12	Guardant Health, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10:40 AM